pharma · Body weight management · Acromegaly
Currus Biologics Pty
Camurus Pty Ltd
Camurus Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Body weight management, Acromegaly, gastroenteropancreatic neuroendocrine tumors. NovaPharmaNews links 3 clinical program(
Melbourne, AU HQ
2021 Founded
11 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Founded
- 2021
- Employees
- 11
- Programs
- 3
- Drugs
- 14
- Patents
- 0
HS-19-647
Phase 3 · small molecule · Acromegaly
HS-19-647 for Acromegaly is a Phase 3 program (small_molecule) at Camurus Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code HS-19-647
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Camurus Pty Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Acromegaly
- Status
- active
- Trials
- 1